MedPath

To evaluate the Safety and efficacy of Unani formulations in the treatment of Amnesia.

Phase 2
Conditions
Health Condition 1: null- Nisyan (Amnesia)Health Condition 2: R413- Other amnesia
Registration Number
CTRI/2013/09/003978
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1.Patients of both sexes between 18 to 60 yrs.

2.Patients having classical signs and symptoms suggestive of the disease:-

ï??(a)Loss of short-term memory

ï??(b)Loss of past memory

ï??(c)Mixed type of Memory loss

ï??(d)Pseudo-event replacement memory.

ï??(e)Loss of memory associated with Audio- Visual Haulicinations.

ï??(f)Forgetfulness of particular event.

ï??(g)In articulation in memory.

ï??(h)In ability to write, partially or fully in previously writing people .

ï??(i)In ability to read in literate people

ï??(j)In ability to copy a design.

ï??(k)Amnesia with Isolated Systolic Hypertension.

ï??(l)Amnesia with Mild and Moderate hypertension.

Exclusion Criteria

1.Brain Tumours

2.Stroke

3.Space Occupying brain lesions

4.Epilepsy.

5.Amnesia symptoms with D.M.

6.Patients with severe Hypertension.

7.Pt. on any drug related to CNS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath